Total Payments
$4,176
2024 Payments
$478.10
Companies
44
Transactions
146
Medicare Patients
33,483
Medicare Billing
$6.6M
Payment Breakdown by Category
Food & Beverage$3,605 (86.3%)
Travel$458.80 (11.0%)
Education$111.82 (2.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,605 | 140 | 86.3% |
| Travel and Lodging | $458.80 | 1 | 11.0% |
| Education | $111.82 | 5 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Stryker Corporation | $738.76 | 2 | $0 (2018) |
| Daiichi Sankyo Inc. | $457.78 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $339.33 | 9 | $0 (2024) |
| Amgen Inc. | $321.10 | 11 | $0 (2023) |
| Seagen Inc. | $277.66 | 7 | $0 (2021) |
| Genentech USA, Inc. | $259.69 | 11 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $216.09 | 12 | $0 (2024) |
| Janssen Biotech, Inc. | $167.16 | 8 | $0 (2024) |
| PFIZER INC. | $164.46 | 9 | $0 (2024) |
| Octapharma USA, Inc. | $132.18 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $478.10 | 24 | Novartis Pharmaceuticals Corporation ($94.31) |
| 2023 | $638.76 | 30 | AstraZeneca Pharmaceuticals LP ($114.91) |
| 2022 | $502.10 | 28 | Novartis Pharmaceuticals Corporation ($61.47) |
| 2021 | $595.44 | 12 | Seagen Inc. ($146.73) |
| 2020 | $422.17 | 11 | Daiichi Sankyo Inc. ($246.33) |
| 2019 | $309.34 | 14 | Genentech USA, Inc. ($113.40) |
| 2018 | $1,004 | 19 | Stryker Corporation ($738.76) |
| 2017 | $226.34 | 8 | SANOFI-AVENTIS U.S. LLC ($85.53) |
All Payment Transactions
146 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $25.12 | General |
| Category: Hematology | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $43.56 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Oncology | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.96 | General |
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Oncology | ||||||
| 09/03/2024 | Octapharma USA, Inc. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Oncology | ||||||
| 07/31/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $20.20 | General |
| 07/23/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Oncology | ||||||
| 07/16/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Oncology | ||||||
| 06/18/2024 | GENZYME CORPORATION | CABLIVI (Biological), ENJAYMO | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Hematology | ||||||
| 06/11/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $16.05 | General |
| Category: Oncology | ||||||
| 05/14/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Oncology | ||||||
| 05/01/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Oncology | ||||||
| 04/24/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: ONCOLOGY | ||||||
| 04/10/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Oncology | ||||||
| 03/11/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Oncology | ||||||
| 03/05/2024 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $25.83 | General |
| Category: Hematology | ||||||
| 03/02/2024 | Octapharma USA, Inc. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: IMMUNOLOGY | ||||||
| 01/09/2024 | PFIZER INC. | BOSULIF (Drug), BESPONSA, ELREXFIO | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 12/08/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 4,936 | 160,162 | $2.6M | $653,929 |
| 2022 | 53 | 7,692 | 148,662 | $3.5M | $982,984 |
| 2021 | 70 | 9,982 | 189,821 | $7.2M | $2.3M |
| 2020 | 74 | 10,873 | 239,064 | $8.2M | $2.7M |
Total Patients
33,483
Total Services
737,709
Medicare Billing
$6.6M
Procedure Codes
235
All Medicare Procedures & Services
235 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 94 | 11,040 | $563,040 | $200,737 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 731 | 1,350 | $457,650 | $124,743 | 27.3% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 41 | 11,470 | $263,810 | $67,094 | 25.4% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 99 | 102,000 | $408,000 | $40,442 | 9.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 71 | 384 | $145,152 | $37,050 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 441 | 562 | $134,318 | $35,443 | 26.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 1,059 | 2,508 | $22,572 | $21,042 | 93.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 1,074 | 2,731 | $79,199 | $20,715 | 26.2% |
| J0185 | Injection, aprepitant, 1 mg | Office | 2023 | 21 | 11,310 | $56,550 | $15,479 | 27.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 132 | 308 | $58,212 | $14,741 | 25.3% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 108 | 531 | $44,604 | $11,569 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 80 | 80 | $36,240 | $9,797 | 27.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 55 | 70 | $33,180 | $9,577 | 28.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 184 | 640 | $44,160 | $6,656 | 15.1% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 28 | 135 | $24,030 | $6,591 | 27.4% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 104 | 526 | $31,964 | $6,126 | 19.2% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 24 | 153 | $13,617 | $3,664 | 26.9% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 22 | 120 | $9,480 | $2,586 | 27.3% |
| 96411 | Administration of additional new drug or substance into vein using push technique | Office | 2023 | 11 | 56 | $9,520 | $2,356 | 24.7% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 14 | 150 | $8,400 | $2,348 | 28.0% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Office | 2023 | 16 | 17 | $7,939 | $2,287 | 28.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $7,020 | $2,071 | 29.5% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2023 | 33 | 2,010 | $56,280 | $1,603 | 2.8% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 18 | 65 | $10,140 | $1,577 | 15.6% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 37 | 48 | $7,488 | $1,329 | 17.8% |
About Dr. Laura Dickerson, MD
Dr. Laura Dickerson, MD is a Hematology healthcare provider based in Gainesville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417031238.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laura Dickerson, MD has received a total of $4,176 in payments from pharmaceutical and medical device companies, with $478.10 received in 2024. These payments were reported across 146 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($3,605).
As a Medicare-enrolled provider, Dickerson has provided services to 33,483 Medicare beneficiaries, totaling 737,709 services with total Medicare billing of $6.6M. Data is available for 4 years (2020–2023), covering 235 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Medical Oncology
- Location Gainesville, FL
- Active Since 10/25/2006
- Last Updated 05/02/2022
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1417031238
Products in Payments
- HIP ARTHROSCOPY ACCESS & INSTRUMENTATION SET (Device) $738.76
- Enhertu (Drug) $413.36
- TUKYSA (Drug) $277.66
- Nplate (Biological) $161.71
- ENHERTU (Biological) $145.98
- DARZALEX (Biological) $124.81
- TAGRISSO (Drug) $119.32
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) $116.37
- KISQALI (Drug) $108.63
- Herceptin (Biological) $95.92
- HYPERLIPIDEMIA - DISEASE (Drug) $85.53
- XPOVIO (Drug) $84.59
- Pomalyst (Drug) $76.45
- IBRANCE (Drug) $73.50
- PROSIGNA ASSAY (Device) $72.27
- XTANDI (Drug) $65.86
- Cabometyx (Drug) $60.63
- Kyprolis (Drug) $51.48
- KANJINTI (Biological) $49.42
- ENHERTU (Drug) $44.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Gainesville
Vijay Patel, Md, MD
Hematology — Payments: $130,357
Hematology $130,357
Charles Nash, Md, MD
Hematology — Payments: $63,096
Hematology $63,096
Dr. Osama Hlalah, M.d, M.D
Hematology — Payments: $62,619
Hematology $62,619
Lucio Gordan, Md, MD
Hematology — Payments: $52,130
Hematology $52,130
Dr. Venumadhav Kotla, M.d, M.D
Hematology — Payments: $16,706
Hematology $16,706
Timothy Carey, Md, MD
Hematology — Payments: $16,231
Hematology $16,231